Abstract
Summary
The Middle East and Africa medical cannabis market is expected to reach USD 1,218.25 million by 2030 from USD 254.83 million in 2022, growing at a CAGR of 21.7% during the forecast period of 2023 to 2030.
Market Segmentation
Middle East and Africa Medical Cannabis Market, By Product (Oil, Medical Cannabis Capsules, Patch, Whole Flower, Ground Flower, Vape Pen, Dried Medical Cannabis, Creams & Moisturizer, Masks & Serum, Cleanser, and Others), Source (Natural and Synthetic), Species (Cannabis Indica, Sativa, and Hybrid), Application (Alzheimer’s Disease, Appetite Loss, Cancer, Inflammatory Bowel Diseases, Eating Disorders, Epilepsy, Autism, Mental Health Conditions, Multiple Sclerosis, Pain Management, Nausea, Muscle Spasms, Wasting Syndrome (Cachexia), Elevate Mood, Depression and Sleep Disorders, Anxiety, and Others), Derivatives (Cannabidiol (CBD), Tetrahydrocannabinol (THC), Delta-8-tetrahydrocannabinol, Cannabinol (CBN), Cannabicyclol (CBL), Cannabichromene (CBC), Cannabigerol (CBG), and Others), Treatment Type (Expectorant, Antiviral, Analgesic, Aphrodisiac, Psychedelic, and Others), Route of Administration (Oral Solutions and Capsules, Smoking, Vaporizers, Topicals, and Others), End User (Pharmaceutical Industry, Research and Development Centers, Homecare Setting, Hospital, Rehab Centers, and Others), Distribution Channel (B2B and B2C), Country (South Africa, Ethiopia, U.A.E., and Rest of Middle East and Africa) – Industry Trends and Forecast to 2030
Overview of Middle East and Africa Medical Cannabis Market Dynamics
Driver
• Increased medical use of cannabis
Restraint
• The complex regulatory structure for the usage of cannabis
Opportunity
• Novel product development with increasing R&D activities
Market Players
Some of the major market players operating in the Middle East and Africa medical cannabis market are:
• MediPharm Labs Inc.
• Tilray
• Aurora Cannabis
• JAZZ Pharmaceuticals Inc. (GW Pharmaceuticals plc)
• HEXO Corp. (Zenabis Global Ltd)
• Cresco Labs
• Peace Naturals Project Inc.
• CANOPY GROWTH CORPORATION
• Medical Marijuana, Inc.
• Seed Cellar
• EcoGen Biosciences
• CANNABIS SEEDS USA
• Seeds For Me
• HUMBOLDT SEED COMPANY
• Extractas
• World Class Cannabis Seeds (Crop King Seeds)
• BARNEY'S FARM
• FOLIUM BIOSCIENCES
• PharmaHemp
• Elixinol Global Limited
• ENDOCA
• Harmony
• MARY’S nutritionals, LLC
• Pure Ratios
• Greenwich Biosciences, Inc.
• Upstate Elevator Supply Co.
• Apothecanna
• BOL Pharma
• IDT Australia
Table of Contents
1 INTRODUCTION 155
1.1 OBJECTIVES OF THE STUDY 155
1.2 MARKET DEFINITION 155
1.3 OVERVIEW OF THE MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET 155
1.4 LIMITATIONS 157
1.5 MARKETS COVERED 158
2 MARKET SEGMENTATION 167
2.1 MARKETS COVERED 167
2.2 GEOGRAPHICAL SCOPE 168
2.3 YEARS CONSIDERED FOR THE STUDY 169
2.4 CURRENCY AND PRICING 169
2.5 DBMR TRIPOD DATA VALIDATION MODEL 170
2.6 MULTIVARIATE MODELLING 173
2.7 PRODUCT LIFELINE CURVE 173
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 174
2.9 DBMR MARKET POSITION GRID 175
2.10 MARKET APPLICATION COVERAGE GRID 177
2.11 VENDOR SHARE ANALYSIS 178
2.12 SECONDARY SOURCES 179
2.13 ASSUMPTIONS 179
3 EXECUTIVE SUMMARY 180
4 PREMIUM INSIGHTS 183
4.1 PESTEL ANALYSIS 184
4.2 PORTER’S FIVE FORCES 185
5 INDUSTRY INSIGHTS 186
5.1 INDUSTRY INSIGHTS PATENT ANALYSIS 186
5.2 DRUG TREATMENT RATE BY MATURED MARKETS 193
5.3 DEMOGRAPHIC TRENDS: IMPACTS ON ALL INCIDENCE RATES 194
5.4 PATIENT FLOW DIAGRAM 195
5.5 KEY PRICING STRATEGIES 196
5.6 KEY PATIENT ENROLLMENT STRATEGIES 197
6 REGULATORY SCENARIO 198
6.1 SOUTH AFRICA 198
6.2 U.A.E 198
7 MARKET OVERVIEW 199
7.1 DRIVERS 200
7.1.1 INCREASED USE OF CANNABIS IN MEDICINES 200
7.1.2 LEGALIZATION OF CANNABIS 200
7.1.3 STRATEGIC INITIATIVES TAKEN BY KEY PLAYERS 200
7.1.4 RISE IN THE PREVALENCE OF DISEASES THAT REQUIRE THE USE OF CANNABIS 201
7.2 RESTRAINTS 202
7.2.1 COMPLEX REGULATORY STRUCTURE FOR THE USAGE OF CANNABIS 202
7.2.2 ADVERSE EFFECTS DUE TO LONG-TERM USE 202
7.2.3 HIGH-COST PURCHASING AND RUSH FOR PREMIUM QUALITY 203
7.3 OPPORTUNITIES 203
7.3.1 NOVEL PRODUCT DEVELOPMENT WITH INCREASING R&D ACTIVITIES 203
7.3.2 INCREASED ADOPTION OF CANNABIS FOR RECREATIONAL PURPOSES 203
7.3.3 GROWING GERIATRIC POPULATION 204
7.4 CHALLENGES 204
7.4.1 RISE OF THE CANNABIS BLACK MARKET 204
7.4.2 SIDE EFFECTS RELATED TO THE USE OF CANNABIS 205
7.4.3 SHORTAGE OF SKILLED PERSONNEL 205
8 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET, BY PRODUCT 206
8.1 OVERVIEW 207
8.2 OIL 211
8.2.1 OIL, BY TYPE 211
- 8.2.1.1 CBD OIL CONCENTRATES 211
- 8.2.1.2 CBD VAPE OIL 212
- 8.2.1.3 CBD TINCTURES 212
8.2.2 OIL, BY SOURCE 212
- 8.2.2.1 HEMP BASED 212
- 8.2.2.2 MARIJUANA BASED 212
8.2.3 OIL, BY SPECIES 212
- 8.2.3.1 SATIVA 212
- 8.2.3.2 HYBRID 213
- 8.2.3.3 CANNABIS INDICA 213
8.2.4 OIL, BY PRODUCT TYPE 213
- 8.2.4.1 BRANDED 213
- 8.2.4.1.1 PENGUIN CBD OIL 213
- 8.2.4.1.2 FAB CBD OIL 214
- 8.2.4.1.3 GREEN ROADS BROAD SPECTRUM CBD OIL 214
- 8.2.4.1.4 OTHERS 214
- 8.2.4.2 GENERIC 214
- 8.2.4.1 BRANDED 213
8.3 DRIED MEDICAL CANNABIS 214
8.3.1 CANNABIS INDICA 215
8.3.2 SATIVA 215
8.3.3 HYBRID 215
8.4 MEDICAL CANNABIS CAPSULES 216
8.4.1 MEDICAL CANNABIS CAPSULES, BY TYPE 216
- 8.4.1.1 OIL BASED CANNABIS CAPSULES 217
- 8.4.1.2 POWDER BASED CANNABIS CAPSULES 217
- 8.4.1.3 LIQUID BASED CANNABIS CAPSULES 217
- 8.4.1.4 OTHERS 217
8.4.2 MEDICAL CANNABIS CAPSULES, BY CONCENTRATES 217
- 8.4.2.1 HIGH CBD CAPSULES DIGITAL 217
- 8.4.2.2 HIGH THC CAPSULE 217
- 8.4.2.3 THC/CBD BALANCED CAPSULE 218
- 8.4.2.4 CBD ISOLATE CAPSULE 218
8.4.3 MEDICAL CANNABIS CAPSULES, BY SPECIES 218
- 8.4.3.1 SATIVA 218
- 8.4.3.2 CANNABIS INDICA 218
8.4.4 MEDICAL CANNABIS CAPSULES, BY PRODUCT TYPE 218
- 8.4.4.1 BRANDED 219
- 8.4.4.1.1 JOY NUTRITION 219
- 8.4.4.1.2 MEDTERRA ISOLATE CBD GEL CAPSULES 219
- 8.4.4.1.3 LAZARUS NATURALS 219
- 8.4.4.1.4 OTHERS 219
- 8.4.4.2 GENERIC 219
- 8.4.4.1 BRANDED 219
8.5 VAPE PEN 219
8.5.1 VAPE PEN, BY SPECIES 220
- 8.5.1.1 SATIVA 220
- 8.5.1.2 HYBRID 220
- 8.5.1.3 CANNABIS INDICA 221
8.5.2 VAPE PEN, BY PRODUCT TYPE 221
- 8.5.2.1 BRANDED 221
- 8.5.2.1.1 KANDYPENS RUBI 221
- 8.5.2.1.2 SOL E-NECTAR COLLECTOR 221
- 8.5.2.1.3 PAX ERA PRO-OIL VAPE PEN 222
- 8.5.2.2 GENERIC 222
- 8.5.2.1 BRANDED 221
8.6 WHOLE FLOWER 222
8.6.1 WHOLE FLOWER, SPECIES 222
- 8.6.1.1 SATIVA 223
- 8.6.1.2 HYBRID 223
- 8.6.1.3 CANNABIS INDICA 223
8.6.2 WHOLE FLOWER, PRODUCT TYPE 223
- 8.6.2.1 BRANDED 224
- 8.6.2.1.1 ASTER FARMS 224
- 8.6.2.1.2 RA FLOWER 224
- 8.6.2.1.3 BAD APPLE 224
- 8.6.2.2 GENERIC 224
- 8.6.2.1 BRANDED 224
8.7 CREAMS & MOISTURIZER 225
8.7.1 CREAMS & MOISTURIZER, BY SPECIES 225
- 8.7.1.1 SATIVA 226
- 8.7.1.2 HYBRID 226
- 8.7.1.3 CANNABIS INDICA 226
8.7.2 CREAMS & MOISTURIZER, BY PRODUCT TYPE 226
- 8.7.2.1 BRANDED 226
- 8.7.2.1.1 CBDFX MUSCLE & JOINT 227
- 8.7.2.1.2 ASPEN GREEN MUSCLE RELIEF COOLING CREAM 227
- 8.7.2.1.3 MEDTERRA PAIN CREAM 227
- 8.7.2.2 GENERIC 227
- 8.7.2.1 BRANDED 226
8.8 GROUND FLOWER 227
8.8.1 GROUND FLOWER, BY SPECIES 228
- 8.8.1.1 SATIVA 228
- 8.8.1.2 HYBRID 228
- 8.8.1.3 CANNABIS INDICA 228
8.8.2 GROUND FLOWER, BY PRODUCT TYPE 228
- 8.8.2.1 BRANDED 229
- 8.8.2.1.1 ASTER FARMS 229
- 8.8.2.1.2 RA FLOWER 229
- 8.8.2.1.3 BAD APPLE 229
- 8.8.2.2 GENERIC 229
- 8.8.2.1 BRANDED 229
8.9 PATCH 230
8.9.1 PATCH, BY TYPE 230
- 8.9.1.1 RESERVOIR 230
- 8.9.1.2 LAYER DRUG-IN-ADHESIVE 230
- 8.9.1.3 OTHERS 231
8.9.2 PATCH, BY SPECIES 231
- 8.9.2.1 SATIVA 231
- 8.9.2.2 CANNABIS INDICA 231
- 8.9.2.3 HYBRID 231
8.9.3 PATCH, BY PRODUCT TYPE 231
- 8.9.3.1 BRANDED 231
- 8.9.3.1.1 HEMP BOMBS 232
- 8.9.3.1.2 PUREKANA 232
- 8.9.3.1.3 PURE RATIOS 232
- 8.9.3.1.4 RESERVOIR 232
- 8.9.3.2 GENERIC 232
- 8.9.3.1 BRANDED 231
8.10 MASKS & SERUM 233
8.10.1 MASKS & SERUM, BY SPECIES 233
- 8.10.1.1 SATIVA 234
- 8.10.1.2 CANNABIS INDICA 234
- 8.10.1.3 HYBRID 234
8.10.2 MASKS & SERUM, BY PRODUCT TYPE 234
- 8.10.2.1 BRANDED 234
- 8.10.2.1.1 BUMP & SMOOTH CBD 234
- 8.10.2.1.2 FACIAL ESSENCE 235
- 8.10.2.1.3 OTHERS 235
- 8.10.2.2 GENERIC 235
- 8.10.2.1 BRANDED 234
8.11 CLEANSER 235
8.11.1 CLEANSER, BY SPECIES 235
- 8.11.1.1 SATIVA 236
- 8.11.1.2 HYBRID 236
- 8.11.1.3 CANNABIS INDICA 236
8.11.2 CLEANSER, BY PRODUCT TYPE 236
- 8.11.2.1 BRANDED 237
- 8.11.2.1.1 KIEHL’S 237
- 8.11.2.1.2 CBD 101 237
- 8.11.2.1.3 OTHERS 237
- 8.11.2.2 GENERIC 237
- 8.11.2.1 BRANDED 237
8.12 OTHERS 238
9 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET, BY SPECIES 239
9.1 OVERVIEW 240
9.2 SATIVA 243
9.3 HYBRID 244
9.4 CANNABIS INDICA 245
10 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET, BY DERIVATIVES 246
10.1 OVERVIEW 247
10.2 CANNABIDIOL (CBD) 250
10.3 TETRAHYDROCANNABINOL (THC)/DELTA-8-TETRAHYDROCANNABINOL 250
10.4 CANNABIGEROL (CBG) 251
10.5 CANNABICHROMENE (CBC) 252
10.6 CANNABINOL (CBN) 253
10.7 CANNABICYCLOL (CBL) 254
10.8 OTHERS 255
11 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET, BY APPLICATION 256
11.1 OVERVIEW 257
11.2 PAIN MANAGEMENT 261
11.2.1 PAIN MANAGEMENT, BY TYPE 261
- 11.2.1.1 CHRONIC PAIN 261
- 11.2.1.2 NON-CANCER CHRONIC PAIN 262
- 11.2.1.3 NEUROLOGICAL PAIN 262
11.2.2 PAIN MANAGEMENT, BY PRODUCT 262
- 11.2.2.1 OIL 262
- 11.2.2.2 DRIED MEDICAL CANNABIS 262
- 11.2.2.3 MEDICAL CANNABIS CAPSULES 262
- 11.2.2.4 PATCH 263
- 11.2.2.5 GROUND FLOWER 263
- 11.2.2.6 CREAMS & MOISTURIZER 263
- 11.2.2.7 VAPE PEN 263
- 11.2.2.8 WHOLE FLOWER 263
- 11.2.2.9 MASKS & SERUM 263
- 11.2.2.10 CLEANSER 263
- 11.2.2.11 OTHERS 263
11.3 ANXIETY 263
11.3.1 OIL 264
11.3.2 DRIED MEDICAL CANNABIS 264
11.3.3 MEDICAL CANNABIS CAPSULES 265
11.3.4 PATCH 265
11.3.5 GROUND FLOWER 265
11.3.6 CREAMS & MOISTURIZER 265
11.3.7 VAPE PEN 265
11.3.8 WHOLE FLOWER 265
11.3.9 MASKS & SERUM 265
11.3.10 CLEANSER 265
11.3.11 OTHERS 265
11.4 MUSCLE SPASM 266
11.4.1 OIL 267
11.4.2 DRIED MEDICAL CANNABIS 267
11.4.3 MEDICAL CANNABIS CAPSULES 267
11.4.4 PATCH 267
11.4.5 GROUND FLOWER 267
11.4.6 CREAMS & MOISTURIZER 267
11.4.7 VAPE PEN 268
11.4.8 WHOLE FLOWER 268
11.4.9 MASKS & SERUM 268
11.4.10 CLEANSER 268
11.4.11 OTHERS 268
11.5 NAUSEA 268
11.5.1 OIL 269
11.5.2 DRIED MEDICAL CANNABIS 269
11.5.3 MEDICAL CANNABIS CAPSULES 269
11.5.4 PATCH 269
11.5.5 GROUND FLOWER 269
11.5.6 CREAMS & MOISTURIZER 270
11.5.7 VAPE PEN 270
11.5.8 WHOLE FLOWER 270
11.5.9 MASKS & SERUM 270
11.5.10 CLEANSER 270
11.5.11 OTHERS 270
11.6 APPETITE LOSS 270
11.6.1 OIL 271
11.6.2 DRIED MEDICAL CANNABIS 271
11.6.3 MEDICAL CANNABIS CAPSULES 272
11.6.4 PATCH 272
11.6.5 GROUND FLOWER 272
11.6.6 CREAMS & MOISTURIZER 272
11.6.7 VAPE PEN 272
11.6.8 WHOLE FLOWER 272
11.6.9 MASKS & SERUM 272
11.6.10 CLEANSER 272
11.6.11 OTHERS 272
11.7 EATING DISORDERS 273
11.7.1 OIL 274
11.7.2 DRIED MEDICAL CANNABIS 274
11.7.3 MEDICAL CANNABIS CAPSULES 274
11.7.4 PATCH 274
11.7.5 GROUND FLOWER 274
11.7.6 CREAMS & MOISTURIZER 275
11.7.7 VAPE PEN 275
11.7.8 WHOLE FLOWER 275
11.7.9 MASKS & SERUM 275
11.7.10 CLEANSER 275
11.7.11 OTHERS 275
11.8 INFLAMMATORY BOWEL DISEASES 275
11.8.1 OIL 276
11.8.2 DRIED MEDICAL CANNABIS 276
11.8.3 MEDICAL CANNABIS CAPSULES 277
11.8.4 PATCH 277
11.8.5 GROUND FLOWER 277
11.8.6 CREAMS & MOISTURIZER 277
11.8.7 VAPE PEN 277
11.8.8 WHOLE FLOWER 277
11.8.9 MASKS & SERUM 277
11.8.10 CLEANSER 277
11.8.11 OTHERS 277
11.9 CANCER 278
11.9.1 OIL 279
11.9.2 DRIED MEDICAL CANNABIS 279
11.9.3 MEDICAL CANNABIS CAPSULES 279
11.9.4 PATCH 279
11.9.5 GROUND FLOWER 279
11.9.6 CREAMS & MOISTURIZER 280
11.9.7 VAPE PEN 280
11.9.8 WHOLE FLOWER 280
11.9.9 MASKS & SERUM 280
11.9.10 CLEANSER 280
11.9.11 OTHERS 280
11.10 ARTHRITIS 280
11.10.1 OIL 281
11.10.2 DRIED MEDICAL CANNABIS 281
11.10.3 MEDICAL CANNABIS CAPSULES 281
11.10.4 PATCH 281
11.10.5 GROUND FLOWER 281
11.10.6 CREAMS & MOISTURIZER 282
11.10.7 VAPE PEN 282
11.10.8 WHOLE FLOWER 282
11.10.9 MASKS & SERUM 282
11.10.10 CLEANSER 282
11.10.11 OTHERS 282
11.11 WASHING SYNDROME (CACHEXIA) 282
11.11.1 OIL 283
11.11.2 DRIED MEDICAL CANNABIS 283
11.11.3 MEDICAL CANNABIS CAPSULES 283
11.11.4 PATCH 283
11.11.5 GROUND FLOWER 283
11.11.6 CREAMS & MOISTURIZER 284
11.11.7 VAPE PEN 284
11.11.8 WHOLE FLOWER 284
11.11.9 MASKS & SERUM 284
11.11.10 CLEANSER 284
11.11.11 OTHERS 284
11.12 ALZHEIMER’S DISEASE 284
11.12.1 OIL 285
11.12.2 DRIED MEDICAL CANNABIS 285
11.12.3 MEDICAL CANNABIS CAPSULES 286
11.12.4 PATCH 286
11.12.5 GROUND FLOWER 286
11.12.6 CREAMS & MOISTURIZER 286
11.12.7 VAPE PEN 286
11.12.8 WHOLE FLOWER 286
11.12.9 MASKS & SERUM 286
11.12.10 CLEANSER 286
11.12.11 OTHERS 286
11.13 EPILEPSY 287
11.13.1 OIL 288
11.13.2 DRIED MEDICAL CANNABIS 288
11.13.3 MEDICAL CANNABIS CAPSULES 288
11.13.4 PATCH 288
11.13.5 GROUND FLOWER 288
11.13.6 CREAMS & MOISTURIZER 289
11.13.7 VAPE PEN 289
11.13.8 WHOLE FLOWER 289
11.13.9 MASKS & SERUM 289
11.13.10 CLEANSER 289
11.13.11 OTHERS 289
11.14 DEPRESSION AND SLEEP DISORDER 289
11.14.1 OIL 290
11.14.2 DRIED MEDICAL CANNABIS 290
11.14.3 MEDICAL CANNABIS CAPSULES 291
11.14.4 PATCH 291
11.14.5 GROUND FLOWER 291
11.14.6 CREAMS & MOISTURIZER 291
11.14.7 VAPE PEN 291
11.14.8 WHOLE FLOWER 291
11.14.9 MASKS & SERUM 291
11.14.10 CLEANSER 291
11.14.11 OTHERS 291
11.15 MULTIPLE SCLEROSIS 292
11.15.1 OIL 293
11.15.2 DRIED MEDICAL CANNABIS 293
11.15.3 MEDICAL CANNABIS CAPSULES 293
11.15.4 PATCH 293
11.15.5 GROUND FLOWER 293
11.15.6 CREAMS & MOISTURIZER 294
11.15.7 VAPE PEN 294
11.15.8 WHOLE FLOWER 294
11.15.9 MASKS & SERUM 294
11.15.10 CLEANSER 294
11.15.11 OTHERS 294
11.16 AUTISM 294
11.16.1 OIL 295
11.16.2 DRIED MEDICAL CANNABIS 295
11.16.3 MEDICAL CANNABIS CAPSULES 296
11.16.4 PATCH 296
11.16.5 GROUND FLOWER 296
11.16.6 CREAMS & MOISTURIZER 296
11.16.7 VAPE PEN 296
11.16.8 WHOLE FLOWER 296
11.16.9 MASKS & SERUM 296
11.16.10 CLEANSER 296
11.16.11 OTHERS 296
11.17 MENTAL HEALTH CONDITIONS 296
11.17.1 MENTAL HEALTH CONDITIONS, BY TYPE 297
- 11.17.1.1 POSTTRAUMATIC STRESS DISORDER (PTSD) 297
- 11.17.1.2 SCHIZOPHRENIA 297
- 11.17.1.3 OTHERS 297
11.17.2 MENTAL HEALTH CONDITIONS, BY TYPE 298
- 11.17.2.1 OIL 298
- 11.17.2.2 DRIED MEDICAL CANNABIS 298
- 11.17.2.3 MEDICAL CANNABIS CAPSULES 298
- 11.17.2.4 PATCH 298
- 11.17.2.5 GROUND FLOWER 298
- 11.17.2.6 CREAMS & MOISTURIZER 299
- 11.17.2.7 VAPE PEN 299
- 11.17.2.8 WHOLE FLOWER 299
- 11.17.2.9 MASKS & SERUM 299
- 11.17.2.10 CLEANSER 299
- 11.17.2.11 OTHERS 299
11.18 ELEVATE MOOD 299
11.18.1 OIL 300
11.18.2 DRIED MEDICAL CANNABIS 300
11.18.3 MEDICAL CANNABIS CAPSULES 301
11.18.4 PATCH 301
11.18.5 GROUND FLOWER 301
11.18.6 CREAMS & MOISTURIZER 301
11.18.7 VAPE PEN 301
11.18.8 WHOLE FLOWER 301
11.18.9 MASKS & SERUM 301
11.18.10 CLEANSER 301
11.18.11 OTHERS 301
11.19 OTHERS 302
12 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION 303
12.1 OVERVIEW 304
12.2 ORAL SOLUTIONS AND CAPSULES 307
12.3 SMOKING 308
12.4 TOPICALS 308
12.5 VAPORIZERS 309
12.6 OTHERS 310
13 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET, BY TREATMENT TYPE 311
13.1 OVERVIEW 312
13.2 ANALGESIC 315
13.3 PSYCHEDELIC 315
13.4 ANTIVIRAL 316
13.5 APHRODISIAC 317
13.6 EXPECTORANT 317
13.7 OTHERS 318
14 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET, BY END USER 319
14.1 OVERVIEW 320
14.2 HOMECARE SETTING 323
14.3 HOSPITAL 323
14.4 REHAB CENTERS 324
14.5 PHARMACEUTICAL INDUSTRY 325
14.6 RESEARCH AND DEVELOPMENT CENTERS 326
14.7 OTHERS 326
15 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL 327
15.1 OVERVIEW 328
15.2 B2C 331
15.2.1 PHARMACIES 332
15.2.2 CONVENTIONAL STORES 332
15.2.3 ONLINE STORES 332
15.2.4 OTHERS 332
15.3 B2B 332
16 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET, BY REGION 333
16.1 MIDDLE EAST AND AFRICA 334
16.1.1 ISRAEL 360
16.1.2 SOUTH AFRICA 381
16.1.3 LEBANON 403
16.1.4 U.A.E 424
16.1.5 KUWAIT 446
16.1.6 REST OF MIDDLE EAST AND AFRICA 467
17 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: COMPANY LANDSCAPE 468
17.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA 468
18 COMPANY PROFILE 469
18.1 MEDIPHARM LABS INC 469
18.1.1 COMPANY SNAPSHOT 469
18.1.2 REVENUE ANALYSIS 470
18.1.3 COMPANY SHARE ANALYSIS 470
18.1.4 PRODUCT PORTFOLIO 471
18.1.5 RECENT DEVELOPMENTS 471
18.2 TILRAY 473
18.2.1 COMPANY SNAPSHOT 473
18.2.2 COMPANY SHARE ANALYSIS 473
18.2.3 PRODUCT PORTFOLIO 474
18.2.4 RECENT DEVELOPMENTS 474
18.3 AURORA CANNABIS 475
18.3.1 COMPANY SNAPSHOT 475
18.3.2 REVENUE ANALYSIS 475
18.3.3 COMPANY SHARE ANALYSIS 476
18.3.4 PRODUCT PORTFOLIO 476
18.3.5 RECENT DEVELOPMENTS 476
18.4 JAZZ PHARMACEUTICALS INC. (GW PHARMACEUTICALS PLC) 478
18.4.1 COMPANY SNAPSHOT 478
18.4.2 REVENUE ANALYSIS 478
18.4.3 COMPANY SHARE ANALYSIS 479
18.4.4 PRODUCT PORTFOLIO 479
18.4.5 RECENT DEVELOPMENTS 479
18.5 HEXO CORP. (ZENABIS MIDDLE EAST & AFRICA LTD) 481
18.5.1 COMPANY SNAPSHOT 481
18.5.2 REVENUE ANALYSIS 481
18.5.3 COMPANY SHARE ANALYSIS 482
18.5.4 PRODUCT PORTFOLIO 482
18.5.5 RECENT DEVELOPMENTS 483
18.6 APOTHECANNA 484
18.6.1 COMPANY SNAPSHOT 484
18.6.2 PRODUCT PORTFOLIO 484
18.6.3 RECENT DEVELOPMENT 485
18.7 BOL PHARMA 486
18.7.1 COMPANY SNAPSHOT 486
18.7.2 PRODUCT PORTFOLIO 486
18.7.3 RECENT DEVELOPMENTS 486
18.8 BARNEY’S FARM 487
18.8.1 COMPANY SNAPSHOT 487
18.8.2 PRODUCT PORTFOLIO 487
18.8.3 RECENT DEVELOPMENTS 488
18.9 CANOPY GROWTH CORPORATION 489
18.9.1 COMPANY SNAPSHOT 489
18.9.2 REVENUE ANALYSIS 489
18.9.3 PRODUCT PORTFOLIO 490
18.9.4 RECENT DEVELOPMENTS 490
18.10 CANNABIS SEEDS USA 492
18.10.1 COMPANY SNAPSHOT 492
18.10.2 PRODUCT PORTFOLIO 492
18.10.3 RECENT DEVELOPMENT 494
18.11 CRESCO LABS 495
18.11.1 COMPANY SNAPSHOT 495
18.11.2 PRODUCT PORTFOLIO 495
18.11.3 RECENT DEVELOPMENTS 497
18.12 ECOGEN BIOSCIENCES 498
18.12.1 COMPANY SNAPSHOT 498
18.12.2 PRODUCT PORTFOLIO 498
18.12.3 RECENT DEVELOPMENTS 498
18.13 ELIXINOL MIDDLE EAST & AFRICA LIMITED 499
18.13.1 COMPANY SNAPSHOT 499
18.13.2 REVENUE ANALYSIS 499
18.13.3 PRODUCT PORTFOLIO 500
18.13.4 RECENT DEVELOPMENTS 500
18.14 ENDOCA 501
18.14.1 COMPANY SNAPSHOT 501
18.14.2 PRODUCT PORTFOLIO 501
18.14.3 RECENT DEVELOPMENT 501
18.15 EXTRACTAS 502
18.15.1 COMPANY SNAPSHOT 502
18.15.2 PRODUCT PORTFOLIO 502
18.15.3 RECENT DEVELOPMENT 502
18.16 FOLIUM BIOSCIENCES 503
18.16.1 COMPANY SNAPSHOT 503
18.16.2 PRODUCT PORTFOLIO 503
18.16.3 RECENT DEVELOPMENTS 504
18.17 GREENWICH BIOSCIENCES, INC 505
18.17.1 COMPANY SNAPSHOT 505
18.17.2 PRODUCT PORTFOLIO 505
18.17.3 RECENT DEVELOPMENTS 505
18.18 HARMONY 506
18.18.1 COMPANY SNAPSHOT 506
18.18.2 PRODUCT PORTFOLIO 506
18.18.3 RECENT DEVELOPMENTS 506
18.19 HUMBOLDT SEED COMPANY 507
18.19.1 COMPANY SNAPSHOT 507
18.19.2 PRODUCT PORTFOLIO 507
18.19.3 RECENT DEVELOPMENT 508
18.20 IDT AUSTRALIA 509
18.20.1 COMPANY SNAPSHOT 509
18.20.2 REVENUE ANALYSIS 509
18.20.3 PRODUCT PORTFOLIO 510
18.20.4 RECENT DEVELOPMENTS 510
18.21 MARY’S NUTRITIONALS, LLC 512
18.21.1 COMPANY SNAPSHOT 512
18.21.2 PRODUCT PORTFOLIO 512
18.21.3 RECENT DEVELOPMENT 512
18.22 MEDICAL MARIJUANA, INC 513
18.22.1 COMPANY SNAPSHOT 513
18.22.2 REVENUE ANALYSIS 513
18.22.3 PRODUCT PORTFOLIO 514
18.22.4 RECENT DEVELOPMENTS 514
18.23 PEACE NATURALS PROJECT INC 515
18.23.1 COMPANY SNAPSHOT 515
18.23.2 PRODUCT PORTFOLIO 515
18.23.3 RECENT DEVELOPMENT 515
18.24 PHARMAHEMP 516
18.24.1 COMPANY SNAPSHOT 516
18.24.2 PRODUCT PORTFOLIO 516
18.24.3 RECENT DEVELOPMENT 516
18.25 PURE RATIOS 517
18.25.1 COMPANY SNAPSHOT 517
18.25.2 PRODUCT PORTFOLIO 517
18.25.3 RECENT DEVELOPMENT 517
18.26 SEEDS FOR ME 518
18.26.1 COMPANY SNAPSHOT 518
18.26.2 PRODUCT PORTFOLIO 518
18.26.3 RECENT DEVELOPMENT 518
18.27 SEED CELLAR 519
18.27.1 COMPANY SNAPSHOT 519
18.27.2 PRODUCT PORTFOLIO 519
18.27.3 RECENT DEVELOPMENT 520
18.28 UPSTATE ELEVATOR SUPPLY CO 521
18.28.1 COMPANY SNAPSHOT 521
18.28.2 PRODUCT PORTFOLIO 521
18.28.3 RECENT DEVELOPMENT 521
18.29 WORLD CLASS CANNABIS SEEDS (CROP KING SEEDS) 522
18.29.1 COMPANY SNAPSHOT 522
18.29.2 PRODUCT PORTFOLIO 522
18.29.3 RECENT DEVELOPMENT 523
19 QUESTIONNAIRE 524
20 RELATED REPORTS 529